The table below shows GLOBUS MEDICAL INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$753.45M
$520.64M
$243.50M
$178.47M
$276.27M
$198.79M
Capital expenditure
$164.68M
$115.43M
$78.27M
$74.05M
$56.90M
$63.66M
Investing cash flow
-$355.01M
-$176.05M
$302.97M
-$110.36M
-$375.94M
-$117.32M
Dividends paid
-
-
-
-
-
GMED operating cash flow (10-K history)
GLOBUS MEDICAL INC reported operating cash flow of $753.45M for fiscal year 2025. That is up 44.7% from $520.64M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $147.82M (FY 2016) to $753.45M. Figures come from the company's audited annual reports as filed with the SEC.
